The combined effect of metformin and mirabegron on diet‐induced obesity
Abstract Anti‐obesity medications act by suppressing energy intake (EI), promoting energy expenditure (EE), or both. Metformin (Met) and mirabegron (Mir) cause weight loss by targeting EI and EE, respectively. However, anti‐obesity effects during concurrent use of both have yet to be explored. In th...
Saved in:
Main Authors: | Xin‐Yuan Zhao, Ying Liu, Xuan Zhang, Ben‐Chi Zhao, George Burley, Zhi‐Can Yang, Yi Luo, An‐Qi Li, Ruo‐Xin Zhang, Zhi‐Ying Liu, Yan‐Chuan Shi, Qiao‐Ping Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | MedComm |
Subjects: | |
Online Access: | https://doi.org/10.1002/mco2.207 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladder
by: Zhipeng Zhang, et al.
Published: (2025-01-01) -
Efficacy and safety of the metformin-mazindol anorectic combination in rat
by: Argüelles-Tello Federico, et al.
Published: (2021-06-01) -
Metformin in the treatment of colorectal cancer and neuroendocrine tumours
by: Karolina Daniłowska, et al.
Published: (2024-08-01) -
Effect of metformin on the level of aqueous humor inflammatory cytokines in patients with cataract
by: Jiaxi Li, et al.
Published: (2025-01-01) -
Metformin for neurocognitive dysfunction in schizophrenia: a systematic review
by: Zhen-Juan Qin, et al.
Published: (2025-01-01)